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We present a case of Corynebacterium pseudotuberculosis
pneumonia in a veterinary student, with molecular genetic
evidence of acquisition during laboratory work, an observa-
tion relevant for laboratory personnel working with C pseu-
dotuberculosis isolates. The patient was clinically cured with
14 months trimethoprim/sulfamethoxazole and rifampicin
combination treatment.
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CASE REPORT
A 23-year-old, previously healthy female veterinary student pre-
sented to hospital in July 2007 with a 4-week history of mild
airway symptoms with initial globus sensation and dysphagia
developing to cough with intermittent purulent expectorate,
some night sweats, but no fever. Computed tomography (CT)
of the thorax revealed a 60 mm consolidated structure in the
posterior upper lobe with enlarged lymph nodes in the right
hilum and mediastinum (Figure 1A and B). Laboratory analysis
revealed moderate increase in inﬂammation markers with
sedimentation rate 30 mm/hour, C-reactive protein (CRP)
33 mg/L, leukocytes 13.2 × 109 cells/L with slight neutrophilia;
8.0 × 109 cells/L, moderate eosinophilia; 2.4 × 109 cells/L and
thrombocytosis; 480 × 109 cells/L. She initially received 2 cours-
es of macrolide treatment and 1 course with penicillin V with-
out clinical response. Infectious serology samples were negative
(Pertussis, Mycoplasma, Chlamydophila, Francisella, Puumula,
Toxoplasma, and human immunodeﬁciency virus) as well as
markers of immune-mediated disease (antinuclear antibodies
and antineutrophil cytoplasmic antibodies). Angiotensin-
converting enzyme was also in the normal range. Two broncho-
scopy procedures with 2 bronchoalveolar lavages (BAL) and 1
blind transbronchial biopsy were performed in September and
October 2007. Microbiological cultivation of BAL showed normal
airway ﬂora at both occasions, and in the lung biopsy Streptococ-
cus salivarius was found; however, these ﬁndings were not consid-
ered clinically relevant. Neither atypical bacteria (Mycoplasma,
Chlamydophila or Legionella), yeast or airways virus were found.
Mycobacterium tuberculosis PCR was positive in the ﬁrst BAL
sample. However, this sample was transported in an inadequate
medium (Copan viral transport medium) and in the second
BAL, transported in isotonic salt water, the Mycobacterium
tuberculosis PCR was negative, furthermore there were negative
Mycobacterium cultures on both occasions. Thus, we believe
that the ﬁrst Mycobacterium tuberculosis PCR was false positive.
In December 2007, a CT-guided transthoracic ﬁne-needle
biopsies from the inﬁltrate in the right upper lung lobe was
performed. The biopsies were immediately transported in isoton-
ic salt water to the microbiological department for analysis.
Corynebacterium spp was identiﬁed from cultures by means of
Gram stain, catalase reaction, and Api Coryne (bioMérieux sa,
Marcy l’Etoile, France). Api Coryne gave low discrimination
(84%) for Corynebacterium renale group. Corynebacterium
ulcerans, but notCorynebacterium pseudotuberculosis, is included
in the Api Coryne identiﬁcation database. Histological examina-
tion revealed necrotic material with signs of granulomatous
inﬂammation; the pathologist observed rod-shaped bacteria.
DNA extracted from the lung biopsy was ampliﬁed and se-
quenced (ABI Prism 3730 DNA analyzer; Applied Biosystems,
Foster City, CA) using 2 primers within the 16S rRNA gene
(5′-AGAGTTTGATCCTGGCTCAG and 5′-GTATTACCGC
GGCTGCTG). The obtained sequence was compared with
sequences in the National Center for Biotechnology Information
database using BLAST (version 2.2.17) and revealed, as the only
species, a 100% shared identity with C pseudotuberculosis. Sus-
ceptibility testing was done according to the instructions from bi-
oMérieux sa, and the minimum inhibitory concentrations
(MICs) were read after 48 hours of incubation at 37°C. Break
points for susceptibility testing were not standardized for this
bacterium in 2008, but the isolate was considered susceptible to
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the antimicrobial agents tested (penicillin, trimethoprim/sulfa-
methoxazole, clindamycin, erythromycin, rifampicin, and tetra-
cycline) due to the low MIC levels (Table 1). When this
bacterium, which rarely causes human disease, was identiﬁed,
contagion during veterinary studies was suspected. The patient
had not been exposed to ungulates during the previous weeks
but recalled that she had classes in veterinary microbiology, in-
cluding work with C pseudotuberculosis cultures, approximately
3 weeks before debut of symptoms. The patient received treat-
ment with 200 mg of doxycycline daily for the ﬁrst 2 weeks fol-
lowed by 100 mg daily for the next 2 weeks. Clinically, the patient
was in good shape, but she had persistent productive cough and
still had some night sweats. A CT scan in February 2008 showed
no major differences from July 2007, but the sedimentation rate,
CRP, and leukocyte levels were normalized. A supplementary 18-
ﬂuorine positron emission tomography (PET)-CT was per-
formed in April 2008, displaying marked metabolic activity in
the lung lesion as well as in a lymph node conglomerate in the
hilum and mediastinum (Figure 2). Consequently, a second
CT-guided ﬁne-needle lung biopsy was done in June 2008. His-
tological ﬁndings were unchanged from the examination 6
months earlier. Corynebacterium pseudotuberculosis was again
detected both by cultivation and by 16S rDNA PCR, sequencing
directly from the biopsied material. Compared with previous
analysis, the isolate displayed no signiﬁcant changes in MIC lev-
els (Table 1). Polymerase chain reaction and cultivation for M
Figure 1. (A and B; 2007) Contrast-enhanced chest computed tomography showing a 60 mm consolidation in the posterior upper right lobe in July 2007
(A) (courtesy of Centrum Radiology Institute, Oslo). There were concomitant enlarged lymph nodes in the right hilum and in the mediastinum in November
2007 (B) (courtesy of Department of Radiology, Drammen Hospital). (C and D; 2013) Nonenhanced chest computed tomography showing the lung lesion
reduced to 20 mm (C). Except for one 18 mm calciﬁed lymph node, the right hilum and mediastinum were normalized (D) (courtesy of Department of Ra-
diology, Drammen Hospital).
Table 1. Minimal Inhibition Concentration (MIC) by Gradient Diffusion Antibiotic Susceptibility Testing (Etest, BioMérieux sa, Marcy
l’Etoile, France) of Corynebacterium pseudotuberculosis
MIC (mg/L) Penicillin Trimethoprim-Sulfamethoxazol Clindamycin Rifampicin Tetracyclin
Isolate 2007 0.064 0.125 0.125 0.002 0.064
Isolate 2008 0.094 0.125 0.064 0.002 0.032
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tuberculosis complex were still negative. In June 2008, she was
treated with the combination of trimethoprim/sulfamethoxazole
and rifampicin. After 6–7 weeks, the cough and night sweats
gradually disappeared. The treatment was continued for the fol-
lowingmonths, and a new CT scan inMay 2009 showedminimal
changes from 1 year earlier, prompting continued treatment.
Thus, 14 months treatment of trimethoprim/sulfamethoxazole
and rifampicin was given in total. During the following 4 years,
the patient has had some intermittent stinging chest pain but no
relapse of cough or night sweats. The inﬂammation markers have
been in the normal range during this period. A CT scan in Oc-
tober 2013, 4 years after treatment was completed, showed that
the lung lesion was reduced to 20 mm with some calciﬁcation
of a single lymph node, otherwise the hilum and mediastinum
were normalized (Figure 1C and D). Since 2007, the patient
has regularly performed lung function tests, always with normal
results. She is now working full time as a veterinarian.
Genomic Analysis
Genomic analysis was performed to elucidate the possibility of
contagion during veterinary studies. The isolate used during the
laboratory course originated from goat. The strain isolated from
the patient (48252, CP008922), the course strain (CS_10,
CP008923), the original goat strain (Ft_2193/67, CP008924),
and an equine C pseudotuberculosis reference strain (CCUG
27541, JPJB00000000) have all been sequenced and published
[1]. Efﬁcient Database Framework for Comparative Genome
Analyses using BLAST Score Ratios (EDGAR) was used to com-
pare the genomes and construct a phylogenetic tree of the spe-
cies C pseudotuberculosis, including these genomes (https://
edgar.computational.bio.uni-giessen.de/) [2]. The newick tree-
ﬁles from EDGAR was visualized in TreeView, version 1.6.6
(http://taxonomy.zoology.gla.ac.uk/rod/treeview.html) [3]. The
phylogram shows that the biovar equi strains all cluster together
(C pseudotuberculosis Cp162, 31, 1-06-A, 316, 258 and CIP
5297 [4–9]), whereas the biovar ovis strains [10–14] are divided
into 2 main clusters (Figure 3). The patient strain (48252) and
the course strain (CS_10) are highly similar and cluster together
with the original goat strain (Ft_2193/67). The reference strain
CCUG 27541 cluster together with the other equine strains.
The phylogenetic tree presented includes 1 human strain,
C pseudotuberculosis FRC41, in addition to our patient strain.
This strain, isolated from the inguinal lymph node of a 12-year-
old girl with necrotizing lymphadenitis, clusters in the same main
biovar ovis group as our patient strain, course strain, original goat
strain, and 2 strains isolated from caseous lymphadenitis in sheep
and goat [12, 13, 15]. The course strain of C pseudotuberculosis
was originally isolated fromNorwegian goat herd fromHemsedal,
a mountain valley in Southern Norway, inMay 1967. The animals
demonstrated low appetite with chronic loss of weight.
High similarity between the patient and course strain was
further supported by a comparison of gene content. Most
genes were common between the strains with only 12 genes
unique to the patient strain and 15 genes unique to course strain
(most of these genes code for hypothetical proteins except a pu-
tative antisigma factor and a conserved membrane protein
ML1361 unique to the course strain). The high level of shared
genomic identity between the patient and course strain strongly
supports the hypothesis that the infection was acquired during
laboratory work.
Search for virulence genes and genomic islands potentially
involved in virulence was conducted at the Rapid Annotation
using Subsystem Technology (RAST) server, version 4.0 (http://
rast.nmpdr.org/) [16] and with GIPSy: Genomic Island Prediction
Software (http://www.bioinformatics.org/groups/?group_id=1180)
using Corynebacterium glutamicum strain ATCC 13032 (NC
003450) as the non-pathogenic reference strain. As expected, the
most important known virulence factor for C pseudotuberculosis,
Figure 2. Positron emission tomography computed tomography (PET-CT), April 2008: 18Fluorodeoxyglucose (FDG) PET-CT showing FDG uptake in the lung
lesion. The enlarged hilum lymph nodes also showed marked uptake of FDG (courtesy of Department of Radiology, Oslo University Hospital).
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phospholipase D, was among the potential virulence genes
detected [17]. Several genes involved in iron acquisition were
also detected, most notably the fag operon [18]. Thus, mutations
in the fag operon, located in close proximity to the phospholipase
D gene, has been shown to reduce in vivo virulence of C pseudo-
tuberculosis [18]. Furthermore, putative manganese ABC trans-
porters, as well as a manganese-dependent transcription
regulator, were among the potential virulence genes identiﬁed.
No potential virulence genes unique to the patient strain, com-
pared with the course strain, were detected.
Another potent virulence factor, the diphtheria toxin gene
(tox), has previously been detected in C pseudotuberculosis
strains 31, 992, and 993 (all isolated from buffalo in Egypt), like-
ly as a result of horizontal gene transfer [19–21]. However, this
toxin was not detected in either of our strains.
DISCUSSION
Corynebacterium pseudotuberculosis is a facultative anaerobic
pleomorphic Gram-positive rod ﬁrst identiﬁed and described
as a cause of renal abscess in sheep in 1891 [22]. The microbe
is a well known pathogen in veterinary medicine infecting
ungulates, predominantly sheep and goats, although horses, cat-
tle, and deer may also be infected [23].Caseous lymphadenitis is
the dominant clinical manifestation among affected animals,
but visceral organs including lungs may also be affected [24].
In humans, the ﬁrst case of infection was described in 1966
[25], and until now approximately 30 human cases have been
described, especially among occupationally exposed sheep
farmers in Australia [26]. The mode of transmission is usually
by direct skin and wound contact, but drinking of contaminated
raw goat milk and raw goat cheese may also represent transmis-
sion routes [26, 27]. As in ungulates, most human cases present
as necrotizing granulomatous lymphadenitis [26]. There is 1
previous report on human C pseudotuberculosis pneumonia,
also in a veterinary student, published 35 years ago [28]. This
patient had unspeciﬁc symptoms with fatigue, chills, and dry
cough with a marked initial eosinophilia of 31% in blood and
a left lower lobe inﬁltrate. The patient was given erythromycin
for 2 weeks with clinical, biochemical, and radiological re-
sponse. The source of infection was unclear, but notable also
this student had been working with veterinary microbiology
4 weeks before the development of pneumonia and laboratory
transmission was suspected.
Figure 3. Phylogenetic tree of Corynebacterium pseudotuberculosis. The tree has 3 main clusters, 1 for biovar equi (red) and 2 for biovar ovis (blue).
Corynebacterium pseudotuberculosis 48252 = the patient strain, C pseudotuberculosis CS_10 = the course strain, C pseudotuberculosis Ft_2193/67 = the
original goat strain, and C pseudotuberculosis CCUG 27541 = the equine reference strain.
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In this study, we present the second human case of pneumonia
caused by C pseudotuberculosis in a veterinary student. Biochem-
ical identiﬁcation of C pseudotuberculosis and its differentiation
from other corynebacteria such as C ulcerans is difﬁcult, but
excellent identiﬁcation was obtained by both PCR and sequencing.
Furthermore, the obtained isolates were later retested and
identiﬁed as C pseudotuberculosis by matrix-assisted laser-
desorption/ionization time-of-ﬂight mass spectroscopy (Daltonics,
Bremen, Germany). Thus, the identiﬁcation of C pseudotuber-
culosis as a cause of chronic pneumonia in our patient is well
documented.
The patient history including laboratory work with C pseudo-
tuberculosis 3 weeks before debut of symptoms and the very
high level of shared genomic identity between the course strain
and the patient strain strongly indicate laboratory transmission.
To our knowledge, this is the ﬁrst documented laboratory trans-
mitted infection by this bacterium. Epidemiological studies
among animals have displayed high levels of antibodies towards
C pseudotuberculosis [29], but we do not know whether such
tests have been validated for human purposes. If such tests
were available, screening of veterinaries, students, laboratory
workers, and sheep farmers would be of interest to examine
the degree of exposition in such human settings.
A very strong catalase reaction is generated when C pseudotu-
berculosis is exposed to hydrogen peroxide, routinely performed
in veterinary laboratory courses including the course that our pa-
tient had attended. Performing catalase reactions on C pseudotu-
berculosis cultures produce spread of aerosols, containing viable
bacteria, several centimeters above agar plates, a process both we
(unpublished own data, described in Supplementary data) and
others have observed [30]. Dry aerosol particles with C pseudotu-
berculosismay possibly be transported for relatively long distanc-
es in a laboratory together with air currents. Thus, we believe that
transmission of C pseudotuberculosis to the lungs in our patient
was potentially due to inhalation of bacteria aerosols during
laboratory work. Consequently, our observation may have impli-
cations for how laboratory work with C pseudotuberculosis is
organized to prevent new human cases.
The virulence of C pseudotuberculosis is partly due to their
ability to produce phospholipase D, hydrolyzing sphingomye-
lin in mammalian cell membranes such as in endothelial cells,
with potential establishment and spread of the infection in the
host [26]. Other important virulence factors are proteins in-
volved in iron acquisition, in particular the fag operon, re-
sponsible for extracellular iron acquisition and survival in
hostile environments. The genomic analyses demonstrate
that both phospholipase D and fag operon as well as other po-
tential virulence genes indeed were detected in the sequenced
pathogenic patient strain.
In vitro, C pseudotuberculosis is, like M tuberculosis, able to
survive and grow intracellularly in macrophages, thus escaping
immune responses and causing necrotizing granulomatous
inﬂammation [31]. However, to our knowledge, the exact mech-
anism for this property is unknown.
In vitro, C pseudotuberculosis is usually considered suscep-
tible to a broad range of antibiotics including penicillin, as we
found in our isolate. However, in almost all human cases pre-
viously reported, clinical response is not achieved by drug
therapy alone, and additional surgical excision of the affected
tissue has been necessary for clinical cure [26]. In this C pseu-
dotuberculosis pneumonia, we observed treatment failure with
4 weeks of tetracycline treatment, but we noted gradual clinical
and radiological response with long-term trimethoprim/sulfa-
methoxazole and rifampicin treatment, without need for sur-
gical removal of the infected tissue. The rationale for using
trimethoprim/sulfamethoxazole and rifampicin is the high
concentration of these drugs in lung tissue and the beneﬁcial
intracellular antimicrobial effect [32]. Hence, long-term treat-
ment with an antibiotic possessing intracellular effect may be
necessary because C pseudotuberculosis survive inside
macrophages.
It is interesting to note that only low grade and temporarily
displayed elevated systemic inﬂammation markers were ob-
served early in the disease progress in spite of chronic infection.
Thus, it was the low-grade, enduring symptoms in combination
with radiological changes, in particular observed by PET-CT,
that indicated persistent infection, which was subsequently con-
ﬁrmed by repeated microbiological sampling.
CONCLUSIONS
In conclusion, we hereby present the ﬁrst documented labora-
tory-transmitted infection by C pseudotuberculosis. Moreover,
we believe that transmission was due to inhalation of bacteria
containing aerosols possibly when catalase reactions were per-
formed during a laboratory course. Hence, our observation may
have implications for laboratory personnel working with C
pseudotuberculosis to prevent new cases. Finally, a clinical and
radiological treatment response was achieved with long-term
trimethoprim/sulfamethoxazole and rifampicin combination
treatment, without need for surgical removal of the infected
tissue.
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oxfordjournals.org/).
Acknowledgments
Potential conﬂicts of interest. All authors: No reported conﬂicts.
All authors have submitted the ICMJE Form for Disclosure of Potential
Conﬂicts of Interest.
BRIEF REPORT • OFID • 5
 at N
M
BU
 Cam
pus A
as U
niversitetsbiblioteket on February 18, 2016
http://ofid.oxfordjournals.org/
D
ow
nloaded from
 
References
1. Havelsrud OE, Sorum H, Gaustad P. Genome sequences of Corynebac-
terium pseudotuberculosis strains 48252 (Human, Pneumonia), CS_10
(Lab Strain), Ft_2193/67 (Goat, Pus), and CCUG 27541. Genome
Announc 2014; 2. pii: e00869-14. doi: 10.1128/genomeA.00869-14.
2. Blom J, Albaum SP, Doppmeier D, et al. EDGAR: a software framework
for the comparative analysis of prokaryotic genomes. BMC Bioinfor-
matics 2009; 10. doi 10.1186/1471-2105-10-154.
3. Page RD. TreeView: an application to display phylogenetic trees on per-
sonal computers. Comput Appl Biosci 1996; 12:357–8.
4. Cerdeira LT, Schneider MP, Pinto AC, et al. Complete genome sequence
of Corynebacterium pseudotuberculosis strain CIP 52.97, isolated from a
horse in Kenya. J Bacteriol 2011; 193:7025–6.
5. Pethick FE, Lainson AF, Yaga R, et al. Complete genome sequence of
Corynebacterium pseudotuberculosis strain 1/06-A, isolated from a
horse in North America. J Bacteriol 2012; 194:4476.
6. Ramos RTJ, Silva A, Carneiro AR, et al. Genome sequence of the Cory-
nebacterium pseudotuberculosis Cp316 strain, isolated from the abscess
of a Californian horse. J Bacteriol 2012; 194:6620–1.
7. Hassan SS, Schneider MP, Ramos RT, et al. Whole-genome sequence of
Corynebacterium pseudotuberculosis strain Cp162, isolated from Camel.
J Bacteriol 2012; 194:5718–9.
8. Silva A, Ramos RT, Carneiro AR, et al. Complete genome sequence of
Corynebacterium pseudotuberculosis Cp31, isolated from an Egyptian
buffalo. J Bacteriol 2012; 194:6663–4.
9. Soares SC, Trost E, Ramos RT, et al. Genome sequence of Corynebacte-
rium pseudotuberculosis biovar equi strain 258 and prediction of
antigenic targets to improve biotechnological vaccine production.
J Biotechnol 2013; 167:135–41.
10. Cerdeira LT, Pinto AC, Schneider MP, et al. Whole-genome sequence of
Corynebacterium pseudotuberculosis PAT10 strain isolated from sheep
in Patagonia, Argentina. J Bacteriol 2011; 193:6420–1.
11. Lopes T, Silva A, Thiago R, et al. Complete genome sequence of Cory-
nebacterium pseudotuberculosis strain Cp267, isolated from a Llama.
J Bacteriol 2012; 194:3567–8.
12. Pethick FE, Lainson AF, Yaga R, et al. Complete genome sequences of
Corynebacterium pseudotuberculosis strains 3/99–5 and 42/02-A, isolat-
ed from sheep in Scotland and Australia, respectively. J Bacteriol 2012;
194:4736–7.
13. Ruiz JC, D’Afonseca V, Silva A, et al. Evidence for reductive genome
evolution and lateral acquisition of virulence functions in two Coryne-
bacterium pseudotuberculosis strains. Plos One 2011; 6:e18551. doi:
10.1371/journal.pone.0018551.
14. Silva A, Schneider MP, Cerdeira L, et al. Complete genome sequence of
Corynebacterium pseudotuberculosis I19, a strain isolated from a cow in
Israel with bovine mastitis. J Bacteriol 2011; 193:323–4.
15. Trost E, Ott L, Schneider J, et al. The complete genome sequence of Co-
rynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old
girl with necrotizing lymphadenitis reveals insights into gene-regulatory
networks contributing to virulence. BMC Genomics 2010; 11:728.
16. Overbeek R, Olson R, Pusch GD, et al. The SEED and the Rapid
Annotation of microbial genomes using Subsystems Technology
(RAST). Nucleic Acids Res 2014; 42(D1):D206–D14.
17. Hodgson AL, Carter K, Tachedjian M, et al. Efﬁcacy of an ovine caseous
lymphadenitis vaccine formulated using a genetically inactive form of
the Corynebacterium pseudotuberculosis phospholipase D. Vaccine
1999; 17:802–8.
18. Billington SJ, Esmay PA, Songer JG, Jost BH. Identiﬁcation and role in
virulence of putative iron acquisition genes from Corynebacterium
pseudotuberculosis. FEMS Microbiol Lett 2002; 208:41–5.
19. Soares SC, Silva A, Trost E, et al. The pan-genome of the animal path-
ogen Corynebacterium pseudotuberculosis reveals differences in genome
plasticity between the biovar ovis and equi strains. Plos One 2013; 8:
e53818. doi: 10.1371/journal.pone.0053818.
20. Wong TP, Groman N. Production of diphtheria-toxin by selected iso-
lates of Corynebacterium-ulcerans and Corynebacterium-pseudotuber-
culosis. Infect Immun 1984; 43:1114–6.
21. Maximesc P, Oprişan A, Pop A, Potorac E. Further studies on Coryne-
bacterium species capable of producing diphtheria toxin (C. diphther-
iae, C. ulcerans, C. ovis). J Gen Microbiol 1974; 82:49–56.
22. Preicz H, Guinard L. Pseudo-tuberculosis chez le mouton. J Med Vet
Zoot 1891; 16:563.
23. Lipsky BA, Goldberger AC, Tompkins LS, Plorde JJ. Infections caused
by nondiphtheria corynebacteria. Rev Infect Dis 1982; 4:1220–35.
24. Batey RG. Pathogenesis of caseous lymphadenitis in sheep and goats.
Aust Vet J 1986; 63:269–72.
25. Lopez JF, Wong FM, Quesada J. Corynebacterium pseudotuberculosis.
First case of human infection. Am J Clin Pathol 1966; 46:562–7.
26. Peel MM, Palmer GG, Stacpoole AM, Kerr TG. Human lymphadenitis
due to Corynebacterium pseudotuberculosis: report of ten cases from
Australia and review. Clin Infect Dis 1997; 24:185–91.
27. Goldberger AC, Lipsky BA, Plorde JJ. Suppurative granulomatous
lymphadenitis caused by Corynebacterium ovis (pseudotuberculosis).
Am J Clin Pathol 1981; 76:486–90.
28. Keslin MH, McCoy EL, McCusker JJ, Lutch JS. Corynebacterium pseu-
dotuberculosis. A new cause of infectious and eosinophilic pneumonia.
Am J Med 1979; 67:228–31.
29. Jung BY, Lee SH, Kim HY, et al. Serology and clinical relevance of Co-
rynebacterium pseudotuberculosis in native Korean goats (Capra hircus
coreanae). Trop Anim Health Prod 2015; 47:657–61.
30. Lennox VA, Ackerman VP. Aerosols from the catalase test. Pathology
1986; 18:481.
31. McKean S, Davies J, Moore R. Identiﬁcation of macrophage induced
genes of Corynebacterium pseudotuberculosis by differential ﬂuores-
cence induction. Microbes Infect 2005; 7:1352–63.
32. Jacobs RF, Wilson CB. Intracellular penetration and antimicrobial activ-
ity of antibiotics. J Antimicrob Chemother 1983; 12(Suppl C):13–20.
6 • OFID • BRIEF REPORT
 at N
M
BU
 Cam
pus A
as U
niversitetsbiblioteket on February 18, 2016
http://ofid.oxfordjournals.org/
D
ow
nloaded from
 
